The Digital Platform and Its Emerging Role in Decentralized Clinical Trials

Area of Science:

• Clinical Research Technology
• Digital Health Innovations
• Pharmaceutical Development

Background:

• Decentralized clinical trials (DCTs) are gaining traction, utilizing digital platforms for task completion.
• Digital platforms offer efficient tools for investigators and participants, streamlining trial activities.
• Modular digital platforms align well with DCTs, allowing specific modules for individual trial activities.

Purpose of the Study:

• To summarize the current role of digital platforms in supporting decentralized trial activities.
• To discuss the benefits and challenges of digital platforms for investigators and participants in DCTs.
• To highlight technological limitations and discuss the concept of an ideal, unified DCT.

Main Methods:

• This viewpoint synthesizes current knowledge on digital platforms in DCTs.
• It analyzes the strengths of digital platforms, including centralized data capture and remote monitoring.
• The discussion includes an examination of functional limitations and integration challenges.

Main Results:

• Digital platforms offer significant benefits for DCTs, such as improved workflow and trial management.
• Key strengths include centralized data capture and remote participant monitoring.
• Existing platforms face limitations due to functionality constraints and restricted third-party integration.

Conclusions:

• Digital platforms are crucial for advancing DCTs, but current technology has functional limitations.
• The lack of common data standardization protocols impedes the creation of one-size-fits-all DCT platforms.
• Achieving a fully integrated, unified DCT requires addressing significant development obstacles.